Viewing Study NCT02518958


Ignite Creation Date: 2025-12-25 @ 12:14 AM
Ignite Modification Date: 2026-02-17 @ 10:37 PM
Study NCT ID: NCT02518958
Status: COMPLETED
Last Update Posted: 2019-11-18
First Post: 2015-08-04
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase I, Open-Label, Multiple Ascending Dose Study of RRx-001 and Nivolumab
Sponsor: EpicentRx, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module